Inloggad som:
avslutad_ASC4First
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
avslutad_ASC4First
A phase III, multi-center, open-label, randomized study of oral asciminib versus Investigator selected TKI in patients with newly diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase
A phase III, multi-center, open-label, randomized study of oral asciminib versus Investigator selected TKI in patients with newly diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase
PLACEHOLDER
Mer information om studien för vårdgivare
Studien ändrades senast av: studysonia (2023-08-29)